{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:50:06Z","timestamp":1791467406817,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.051","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T16:56:03Z","timestamp":1687193763000},"page":"4639-4647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-8688","authenticated-orcid":false,"given":"Aleksei","family":"Ekimov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-5722","authenticated-orcid":false,"given":"Arun B.","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Bodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Couzens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitara","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryna","family":"Eichelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othmar G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Gubinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8954-9475","authenticated-orcid":false,"given":"Peter","family":"Rigsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Rockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-5614","authenticated-orcid":false,"given":"Natalya","family":"Savina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn A.N.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2023.06.051_b0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1750-2659.2011.00250.x","article-title":"Confronting the next pandemic\u2014Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27\u201329, 2010","volume":"5","author":"Hardy","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"41","key":"10.1016\/j.vaccine.2023.06.051_b0010","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2015.08.077","article-title":"Conformationally selective biophysical assay for influenza vaccine potency determination","volume":"33","author":"Wen","year":"2015","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2023.06.051_b0015","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1016\/j.vaccine.2017.07.049","article-title":"Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat","volume":"35","author":"Pierce","year":"2017","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2023.06.051_b0020","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1021\/acs.analchem.0c02252","article-title":"Limited tryptic digestion-isotope dilution mass spectrometry (LTD-IDMS): a reagent-free analytical assay to quantify hemagglutinin of A(H5N1) vaccine material","volume":"92","author":"Cooper","year":"2020","journal-title":"Anal Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.051_b0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.vaccine.2009.10.070","article-title":"A novel assay for influenza virus quantification using surface plasmon resonance","volume":"28","author":"Nilsson","year":"2010","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2023.06.051_b0030","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2014.02.049","article-title":"Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency","volume":"32","author":"Khurana","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.051_b0035","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.vaccine.2019.01.083","article-title":"SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring","volume":"37","author":"Durous","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.051_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1128683","article-title":"Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage specific monoclonal antibodies","volume":"14","author":"Narayan","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.051_b0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1750-2659.2012.00375.x","article-title":"Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion","volume":"7","author":"Bodle","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.051_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109616","article-title":"Titer on chip: new analytical tool for influenza vaccine potency determination","volume":"9","author":"Kuck","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.051_b0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/irv.12272","article-title":"A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines","volume":"8","author":"Schmeisser","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.051_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194830","article-title":"An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations","volume":"13","author":"Rajendran","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.051_b0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/irv.12528","article-title":"Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays","volume":"12","author":"Vasudevan","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.051_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56169-5","article-title":"Hemagglutinin quantitative ELISA-based potency assay for trivalent seasonal influenza vaccine using group-specific universal monoclonal antibodies","volume":"9","author":"Chae","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2023.06.051_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10091473","article-title":"Development of an ELISA-based potency assay for Inactivated influenza vaccines using cross-reactive nanobodies","volume":"10","author":"Cheung","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.051_b0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2011.05.014","article-title":"Immunogenicity of low-pH treated whole viral influenza vaccine","volume":"417","author":"Quan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.06.051_b0085","doi-asserted-by":"crossref","unstructured":"Kumru OS, Joshi SB, Smith DE, Middaugh CR, Prusik T, Volkin DB. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals 2014;42(5):237\u201325. 10.1016\/j.biologicals.2014.05.007.","DOI":"10.1016\/j.biologicals.2014.05.007"},{"key":"10.1016\/j.vaccine.2023.06.051_b0090","series-title":"Influenza virus: methods and protocols","first-page":"147","article-title":"Influenza virus surveillance, vaccine strain selection, and manufacture","author":"St\u00f6hr","year":"2012"},{"key":"10.1016\/j.vaccine.2023.06.051_b0095","unstructured":"European Commission. Legislation for the protection of animals used for scientific purposes. https:\/\/ec.europa.eu\/environment\/chemicals\/lab_animals\/legislation_en.htm."},{"key":"10.1016\/j.vaccine.2023.06.051_b0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jviromet.2017.10.011","article-title":"A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines","volume":"251","author":"Buffin","year":"2018","journal-title":"J Virol Methods"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.051_b0105","first-page":"908","article-title":"Geometric means and measures of dispersion","volume":"35","author":"Kirkwood","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2023.06.051_b0110","unstructured":"World Health Organization. 29th report of the expert committee on biological standardization, annex 3. WHO Technical Report 13. Series No 6261978; 1978. https:\/\/www.who.int\/publications\/i\/item\/9241206268."},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.051_b0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/irv.12543","article-title":"Standardisation of inactivated influenza vaccines-Learning from history","volume":"12","author":"Wood","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2023.06.051_b0120","unstructured":"World Health Organization. WHO recommendations on the composition of influenza virus vaccines. https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2022-2023-northern-hemisphere-influenza-season."},{"key":"10.1016\/j.vaccine.2023.06.051_b0125","unstructured":"President\u2019s Council of Advisors on Science and Technology. Report to the president on reengineering the influenza vaccine production enterprise to mee the challenges of pandemic influenza; August 2010. https:\/\/obamawhitehouse.archives.gov\/sites\/default\/files\/microsites\/ostp\/PCAST-Influenza-Vaccinology-Report.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.051_b0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/vaccines3010090","article-title":"Assaying the potency of influenza vaccines","volume":"3","author":"Minor","year":"2015","journal-title":"Vaccines (Basel)"},{"issue":"29","key":"10.1016\/j.vaccine.2023.06.051_b0135","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.vaccine.2018.05.076","article-title":"Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen","volume":"36","author":"Engelhardt","year":"2018","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2023.06.051_b0140","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.vaccine.2018.04.021","article-title":"Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity","volume":"36","author":"Wen","year":"2018","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:27:41Z","timestamp":1759404461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23007260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23007260"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}